STATE OF MICHIGAN RETIREMENT SYSTEM - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF MICHIGAN RETIREMENT SYSTEM ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,081,589
+1.8%
12,074
-3.2%
0.01%0.0%
Q2 2023$1,062,036
+0.5%
12,474
-2.3%
0.01%0.0%
Q1 2023$1,057,049
+4.4%
12,774
-0.8%
0.01%0.0%
Q4 2022$1,012,540
+5.5%
12,874
-0.8%
0.01%0.0%
Q3 2022$960,000
+13.5%
12,9740.0%0.01%
+16.7%
Q2 2022$846,000
+3.2%
12,9740.0%0.01%
+20.0%
Q1 2022$820,000
+21.1%
12,974
+1.7%
0.01%
+25.0%
Q4 2021$677,000
-24.8%
12,7560.0%0.00%
-20.0%
Q3 2021$900,000
+5.0%
12,756
-0.8%
0.01%0.0%
Q2 2021$857,000
-59.1%
12,856
-31.8%
0.01%
-61.5%
Q1 2021$2,093,000
-4.5%
18,856
+2.2%
0.01%
-13.3%
Q4 2020$2,192,000
+36.1%
18,4560.0%0.02%
+15.4%
Q3 2020$1,610,000
-2.1%
18,456
+0.5%
0.01%
-7.1%
Q2 2020$1,644,000
+17.8%
18,356
+31.1%
0.01%
-6.7%
Q1 2020$1,395,000
-18.5%
14,000
-6.0%
0.02%
+7.1%
Q4 2019$1,712,000
-7.7%
14,900
+1.4%
0.01%
-17.6%
Q3 2019$1,854,000
+1.4%
14,700
-3.3%
0.02%0.0%
Q2 2019$1,829,000
+14.9%
15,200
-16.5%
0.02%
+30.8%
Q1 2019$1,592,000
-13.5%
18,200
-1.1%
0.01%
-23.5%
Q4 2018$1,841,000
-15.9%
18,400
-3.7%
0.02%
+6.2%
Q3 2018$2,188,000
+27.1%
19,100
-0.5%
0.02%
+14.3%
Q2 2018$1,722,00019,2000.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders